|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| |||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Option (right to buy) | $ 4.67 | 07/18/2013 | D | 100,000 | (1) | 01/25/2019 | Common Stock | 100,000 | $ 29.08 | 0 | D | ||||
Employee Stock Option (right to buy) | $ 5.61 | 07/18/2013 | D | 70,000 | (2) | 05/26/2020 | Common Stock | 70,000 | $ 28.14 | 0 | D | ||||
Employee Stock Option (right to buy) | $ 7.7 | 07/18/2013 | D | 56,875 | (3) | 03/23/2021 | Common Stock | 56,875 | $ 26.05 | 13,125 | D | ||||
Employee Stock Option (right to buy) | $ 7.7 | 07/18/2013 | D | 13,125 | (4) | 03/23/2021 | Common Stock | 13,125 | (4) | 0 | D | ||||
Employee Stock Option (right to buy) | $ 15 | 07/18/2013 | D | 40,833 | (5) | 02/28/2022 | Common Stock | 40,833 | $ 18.75 | 29,167 | D | ||||
Employee Stock Option (right to buy) | $ 15 | 07/18/2013 | D | 29,167 | (6) | 02/28/2022 | Common Stock | 29,167 | (6) | 0 | D | ||||
Employee Stock Option (right to buy) | $ 0.5 | 07/18/2013 | D | 118,750 | (7) | 10/25/2014 | Common Stock | 118,750 | $ 33.25 | 0 | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
DOLAN TRACI M 20 NORTH MERIDIAN STREET SUITE 200 INDIANAPOLIS, IN 46204 |
Chief Admin. Off. & Secretary |
/s/ Brent D. Mosby, attorney-in-fact for Traci M. Dolan | 07/29/2013 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | This option grant, which provided that 25,000 options would vest and become exercisable on January 26, 2010 and 75,000 options would vest and become exercisable in thirty-six equal monthly installments beginning on February 26, 2010, was cancelled in the merger in exchange for a cash payment of $2,908,000 representing the difference between the exercise price of the option and the market value of the underlying ExactTarget, Inc. common stock on the effective date of the merger ($33.75 per share). |
(2) | This option grant, which provided that 17,500 options would vest and become exercisable on May 27, 2011 and 52,500 options would vest and become exercisable in thirty-six equal monthly installments beginning on June 27, 2011, was cancelled in the merger in exchange for a cash payment of $1,970,150 representing the difference between the exercise price of the option and the market value of the underlying ExactTarget, Inc. common stock on the effective date of the merger ($33.75 per share). |
(3) | This option grant, which provided that 17,500 options would vest and become exercisable on March 24, 2012 and 52,500 options would vest and become exercisable in thirty-six equal monthly installments beginning on April 24, 2012, was cancelled in the merger in exchange for a cash payment of $1,481,593.75 representing the difference between the exercise price of the option and the market value of the underlying ExactTarget, Inc. common stock on the effective date of the merger ($33.75 per share). |
(4) | This option grant, which provided that 17,500 options would vest and become exercisable on March 24, 2012 and 52,500 options would vest and become exercisable in thirty-six equal monthly installments beginning on April 24, 2012, was assumed by salesforce.com, inc. in the merger and replaced with an option to purchase 10,990 shares of salesforce.com, inc. common stock for $9.20 per share. |
(5) | This option grant, which provided that 17,500 options would vest and become exercisable on March 1, 2013 and 52,500 options would vest and become exercisable in thirty-six equal monthly installments beginning on April 1, 2013, was cancelled in the merger in exchange for a cash payment of $765,618.75 representing the difference between the exercise price of the option and the market value of the underlying ExactTarget, Inc. common stock on the effective date of the merger ($33.75 per share). |
(6) | This option grant, which provided that 17,500 options would vest and become exercisable on March 1, 2013 and 52,500 options would vest and become exercisable in thirty-six equal monthly installments beginning on April 1, 2013, was assumed by salesforce.com, inc. in the merger and replaced with an option to purchase 24,422 shares of salesforce.com, inc. common stock for $17.92 per share. |
(7) | This option grant, which was fully vested and exercisable, was cancelled in the merger in exchange for a cash payment of $3,948,437.50 representing the difference between the exercise price of the option and the market value of the underlying ExactTarget, Inc. common stock on the effective date of the merger ($33.75 per share). |